Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies
L Boekel, M Steenhuis, F Hooijberg… - The Lancet …, 2021 - thelancet.com
Background Data are scarce on immunogenicity of COVID-19 vaccines in patients with
autoimmune diseases, who are often treated with immunosuppressive drugs. We aimed to …
autoimmune diseases, who are often treated with immunosuppressive drugs. We aimed to …
[HTML][HTML] Adverse events after first COVID-19 vaccination in patients with autoimmune diseases
L Boekel, LY Kummer, KPJ van Dam… - The Lancet …, 2021 - thelancet.com
June 18, 2021 https://doi. org/10.1016/S2665-9913 (21) 00181-8 digital platforms has had
an adverse impact on diversity and participation from under-represented groups due to …
an adverse impact on diversity and participation from under-represented groups due to …
Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective …
L Boekel, F Hooijberg, EH Vogelzang, YR Besten… - RMD open, 2022 - rmdopen.bmj.com
Background Research on the disease severity of COVID-19 in patients with rheumatic
immune-mediated inflammatory diseases (IMIDs) has been inconclusive, and long-term …
immune-mediated inflammatory diseases (IMIDs) has been inconclusive, and long-term …
Breakthrough infections with the SARS-CoV-2 omicron (B. 1.1. 529) variant in patients with immune-mediated inflammatory diseases
EW Stalman, L Wieske, KPJ van Dam… - Annals of the …, 2022 - ard.bmj.com
Objectives To compare the cumulative incidence and disease severity of reported SARS-
CoV-2 omicron breakthrough infections between patients with immune-mediated …
CoV-2 omicron breakthrough infections between patients with immune-mediated …
Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases
L Wieske, EW Stalman, PJK van Dam… - Annals of the …, 2023 - ard.bmj.com
Patients with immune-mediated inflammatory diseases (IMIDs) may have impaired initial
humoral responses after SARS-CoV-2 vaccination depending on the type of …
humoral responses after SARS-CoV-2 vaccination depending on the type of …